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Introduction to Establishing Medical Reality: Essays in the 
Metaphysics and Epistemology of Biomedical Science  
Harold Kincaid and Jennifer Mckitrick    
Medicine has been a very fruitful source of significant issues for philosophy over the 
last 30 years. The vast majority of the issues discussed have been normative—they have 
been problems in morality and political philosophy that now make up the field called 
bioethics. However, biomedical science presents many other philosophical questions that 
have gotten relatively little attention, particularly topics in metaphysics, epistemology 
and philosophy of science. This volume focuses on problems in these areas as they sur-
face in biomedical science. 
Important changes in philosophy make biomedical science an especially interesting 
area of inquiry. Contemporary philosophy is largely naturalistic in approach—it takes 
philosophy to be constrained by the results of the natural sciences and able to contribute 
to the natural sciences as well. Exactly what those constraints and contributions should 
be is a matter of controversy. What is not controversial is that important questions in phi-
losophy of science and metaphysics are raised by the practice of science. Physics, biology, 
and economics have all drawn extensive philosophical analysis, so much so that philo-
sophical study of these areas have become specialized subdisciplines within philosophy 
of science. Philosophy of medicine approached from the perspective of philosophy of sci-
ence—with important exceptions (Schaffner, 1993; Thagard, 2000)—has been relatively 
undeveloped. 
Nonetheless, medicine should have a central place in epistemological and metaphys-
ical debates over science. It is unarguably the most practically important of the sciences. 
It also draws by the far the greatest resources and research efforts of any area in biol-
ogy. Yet philosophy of biology has focused almost exclusively on evolutionary biology, 
leaving the vast enterprises of immunology, cancer biology, virology, clinical medicine, 
and so on unexplored. Naturalized philosophy has emphasized the important interplay 
of historical and sociological aspects of science with its philosophical interpretation. Bio-
medical science as a large scale social enterprise is a natural target for such approaches. 
Relatedly, within philosophy there has been a growing interest and appreciation for the 
connections between issues of value and issues of fact in science (Kincaid et al., 2007). Bio-
medical science is a paradigm instance where the two intersect. 
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The upshot is that biomedical science is a potential rich area for philosophical investi-
gation in areas outside biomedical ethics. This volume seeks to show that promise and to 
encourage its exploration. 
Aside from this general naturalist philosophical perspective which all the papers in 
this volume share, a number of more specific themes emerge. Not surprisingly, given the 
central place that the concept of disease plays in medicine, the status of natural kinds is a 
recurring concern. Yet that concern surfaces in both a practical and skeptical way: practi-
cal in that concrete issues such as the nature of genetic disease or the reality of mental ill-
ness are at the fore, skeptical in that the notion of a natural kind itself is up for debate. A 
second recurring theme is the contestability of medical knowledge. None of the contrib-
utors argues that medical knowledge is a mere construct, but many are sensitive to the 
complex relations between data, conclusions, and practical necessities that exist in med-
icine. A related and third important theme cutting across the essays is that philosophy 
can learn from what other disciplines have to say about medicine. Medicine has impor-
tant connections to other biological and social sciences; philosophy can gain much from 
interacting with other disciplines such as sociology in trying to understand how medicine 
works. A corollary here of course is that philosophical understanding of general issues in 
metaphysics and philosophy of science has much to learn from medicine and other disci-
plines as well. We expand on these themes below, as a preview to their extensive devel-
opment in the essays to follow. 
The interrelated questions “what is health?” and “what is disease?” are central to the 
philosophy of medicine. The answers to these questions bear on a number of questions re-
lated to medicine. People disagree about which conditions count as diseases, and this has 
implications for what happens in a health care system. The traditional role of medicine 
is to fight disease and restore health. The purpose of health insurance, both public and 
private, is to assist those who suffer from disease. So, it seems important to have a clear 
idea of just what it means for something to be a disease. A key issue in debates over how 
to define disease has been over the role of values in the analysis. While taking a broadly 
naturalistic approach, normativists claim that one cannot adequately define disease with-
out employing value-laden concepts, such as harm, suffering, undesirability, and disabil-
ity. Naturalists, on the other hand, claim to define disease without appeal to values, by 
employing purportedly descriptive concepts like abnormality and biological dysfunction. 
Four papers in this collection carve out four different positions in this debate. 
In “Normality, Disease, and Enhancement,” Theodore Benditt joins the naturalist tra-
dition in claiming that disease can be defined non-normatively, in terms of abnormality. 
He considers several challenges to this view, including the idea that someone can be “dif-
ferent” without thereby being in need of medical treatment. His response is two fold. He 
limits the types of abnormality that count as disease, but admits that his view will count 
more things as diseases than some would like. However, he distinguishes the question of 
whether something qualifies as a disease from the question of whether someone should 
do something about it. Even if something qualifies as a disease by Benditt’s standards, the 
practical implications for medicine are unclear. In this sense, he is skeptical about the con-
cept of normality determining the physician’s role. Another role that the concept of nor-
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mality might play in medicine is rejected by Benditt as well. Whether or not one thinks 
that a physician should always restore normal functioning, one might think that a phy-
sician should do no more than restore normal functioning—in other words, that doctors 
should at most cure diseases, not provide enhancements. Benditt compares this issue to 
the role of “normality” and “enhancement” in athletics. It’s common to think that athletic 
competition should be between normal, rather than enhanced, participants. While Benditt 
finds reasons to limit enhancements in athletic competitions following from the reasons 
competitions are held in the first place, he finds no comparable reasons to limit medi-
cal enhancements generally. Consequently, while the concept of normality plays impor-
tant roles in some areas of life such as athletics, Benditt claims it is largely misplaced in 
medicine. 
In “Holistic Theories of Health as Applicable to Non-human Living Beings,” Lenn-
art Nordenfelt defends the normative or holistic approach against naturalist, bio-statis-
tical approaches. According to the bio-statistical approach, a disease is an internal state 
which is an impairment or environmentally caused limitation of normal functional abil-
ity below typical efficacy, decreasing potential for survival and reproduction. Norden-
felt, on the other hand, defines disease as a bodily or mental process which tends to cause 
an illness—a state of suffering or disability experienced by the subject. While health 
may be thought of as absence of disease, it is better described on this view as a state in 
which a person can realize his or her vital goals (states necessary for minimal happiness 
in the long run) given standard circumstances. Of these two contrasting approaches, it 
seems as though the bio-statistical approach would have wider applicability than a ho-
listic one. While medicine is primarily concerned with the health of people, the concepts 
of health and disease extend to non-humans—animals and even plants. The bio-statis-
tical approach aptly accommodates the application of the concept of disease to nonhu-
mans. Determining whether a plant or animal is unhealthy would be merely a matter of 
determining whether some organ or structure was performing its normal function with 
typical efficacy. It is less clear how to apply the holistic theory of health to non-humans. 
Nordenfelt’s approach defines health and disease in terms of the experiences of suffer-
ing or happiness, and many non-human organisms, most notably plants, are by all ac-
counts, not capable of having these experiences. So, defining health and disease for non-
humans presents a major challenge to holistic accounts as against bio-statistical accounts. 
Nordenfelt tries to meet this challenge by weakening the psychological components of 
the accounts of illness, health, and disease. However, his main claim against the natural-
ists seems to be that most organisms can have various interests (things that are in their in-
terest, not necessarily things they’re consciously interested in) beyond survival and re-
production, and to say that only internal states which threaten survival and reproduction 
count as illnesses for any kind of organism is too narrow a view. 
What if the normativist is right, and the concept of disease is essentially normative? 
What does that entail about the nature of disease? If diseases are normative, are they out 
in the world for doctors and biologists to discover, or do people invent or create diseases 
based on their values? If one is a moral realist, one can maintain that certain things are 
just bad for certain organisms, regardless of anyone’s perception of them as such. This, 
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in turn, would allow the normativist to be a realist about disease. However, if one thinks 
that values only arise when someone values something, whether an organism is diseased 
or healthy would also depend on what people value. If cultures differ with respect to dis-
valuing homosexual desires, deafness, or goiters, for example, whether these conditions 
are diseases would vary from culture to culture. On this view, diseases are constructed 
rather than discovered, and do not exist independent of culture. 
In “The Spread of Disease: How to Understand and Resolve a Dispute about the Re-
ality of Disease,” Robert D’Amico defends realism about disease against this social-con-
structivist approach. While he concedes to the normativist that medical concepts such 
as “health,” “illness,” “pathology,” “suffering,” and “harm” are essentially normative, 
he argues that the concept of “disease” is a special exception, and hence not subject to 
the relativization of other normative concepts. (Hence, D’Amico is a naturalist with re-
spect to diseases, but not with respect to medical concepts generally.) Social construc-
tivists argue that disease states have more in common with aesthetic or moral phenom-
ena than with natural phenomena. Unless one is a thorough-going anti-realist or social 
constructivist, whether something is water, gold, or an acid is determined by something 
beyond the mind of any human perceiver. However, according to the social constructiv-
ist, whether something is ugly, bad, or sick, depends on the social group which makes 
this determination. D’Amico draws on concepts from the philosophy of mind and the 
philosophy of science, namely the distinction between strong and weak supervenience, 
to redescribe this debate. According to D’Amico, the social constructivist’s claim ulti-
mately comes down to the idea that while diseases may weakly supervene on physical 
states of organisms, they do not strongly supervene on such states. After casting his tar-
get in these terms, D’Amico marshals arguments to the contrary. For instance, it is rea-
sonable to think that if a person has kidney disease, then necessarily, any perfect dupli-
cate of that person, no matter the social environment, would have kidney disease. That 
is to say, there can be no difference in disease-state without some difference in physical 
state—strong supervenience holds. 
While D’Amico and Benditt defend naturalist approaches to analyzing disease and 
Nordenfelt defends normitivism, Peter Schwartz challenges the distinction itself. In “De-
cision and Discovery in Defining ‘Disease,’” Schwartz claims that a more meaningful clas-
sification of views is in terms of value-requiring and non-value-requiring on the one hand 
and dysfunction-requiring and non-dysfunction-requiring on the other. So, for example, 
a view that requires a disease to be a dysfunction need not be non-normative. But more 
importantly, Schwartz questions the utility of any of these distinctions. He charges that 
philosophers who offer analyses of disease are struck in the outdated analytic project of 
providing necessary and sufficient conditions for the application of a concept. Once you 
claim to have given necessary and sufficient conditions for having a disease, you open 
yourself up to the trench warfare of counterexamples, struggling to deal with variety of 
bodily states which defy your favored classificatory scheme. However, it has long been 
acknowledged that ordinary concepts are not adequately captured by necessary and suf-
ficient conditions. Ordinary concepts admit of varying degrees of applicability, with bet-
ter, worse, and borderline examples. Arguably, when people call a condition a disease, 
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they are not checking the condition against a list of criteria which it must satisfy. And 
quite plausibly, there is no one uniform concept of disease that we all share. So, rather 
than give an analysis of the ordinary concept of disease, perhaps what philosophers of 
medicine should do is to stipulate a particular concept of disease that will be useful to 
philosophy of medicine or to medicine itself. Schwartz suggests that the dysfunction-re-
quiring accounts, while not an analysis of all or event most concepts of disease, can pro-
vide a useful explication of disease. 
Assuming that disease exists, and that we have some idea what it is, we can further 
explicate the notion by breaking it down into genetic diseases, racially-linked diseases, 
psychological disorders, and many other sub-categories. However, some question the 
reality of these categories used to understand disease. Do these categories correspond 
to real distinctions in nature? Classifications of conditions as mental disorders are par-
ticularly susceptible to criticism that they merely reflect societal expectations, as the es-
says of McKitrick and Horwitz suggest (see below). Other essays in this volume explore 
related ontological/classificatory questions. Is it possible or meaningful to classify some 
diseases as genetic and others as nongenetic? Or does doing so reflect a misguided ei-
ther/or attitude towards genetic determinism? While the category of race has been 
eliminated from most scientific contexts, can we still establish meaningful correlations 
between race and disease? 
In “Race and Scientific Reduction,” Mark Risjord notes that epidemiological research 
has identified a number of important correlations between race and health. Blacks suf-
fer higher rates of HIV infection, diabetes, hyper-tension, and cardiovascular disease 
than whites. Since race has been eliminated from biology, this data is philosophically 
puzzling. If epidemiology and the other health sciences are based on biology, one 
would expect race to be eliminated from these disciplines too. Risjord sheds light on 
this puzzle by reflecting on scientific reduction and elimination more generally. Con-
cepts like heat can be reduced to more fundamental scientific concepts, whereas con-
cepts like phlogiston are better eliminated altogether. Should the concept of race be re-
duced, eliminated, or neither? According to “promiscuous realism,” the study of race in 
medicine and the social sciences is ontologically autonomous—race exists as a social or 
medical entity, but not as a biological one. Against the promiscuous realists, Risjord ar-
gues for a causal-explanatory criterion of ontological commitment. Since, according to 
Risjord, race does not meet this criterion, race has rightfully undergone an ontological 
reduction, or elimination, at all levels. Race does not exist. However, questions about 
race and racial discrimination at the social and medical levels remain important. Risjord 
retains the role of the concept of race in these realms by distinguishing between epis-
temic and ontological reductions. While race has been ontologically reduced, it has not 
been epistemically reduced. This distinction allows Risjord to maintain the seemingly 
paradoxical conclusion that the study of race in medicine and the social sciences re-
mains autonomous of biology, but neither medicine, sociology, nor biology are commit-
ted to the existence of race. 
In “Towards an Adequate Account of Genetic Disease,” Kelly Smith asks “What ex-
actly is a genetic disease?” For a phrase one hears on a daily basis, there has been surpris-
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ingly little analysis of the underlying concept. Medical doctors seem perfectly willing to 
admit that the causal origins of diseases are typically complex, with a great many factors 
interacting to bring about a given condition. On such a view, descriptions of diseases like 
cancer as genetic seem at best highly simplistic, and at worst philosophically indefensible. 
On the other hand, there is clearly some practical value to be had by classifying diseases 
according to their predominant cause when this can be accomplished in a theoretically 
satisfactory manner. The question therefore becomes exactly how one should go about 
selecting a single causal factor among many to explain the presence of disease. Smith ar-
gues that previous attempts to defend such causal selection have been clearly inadequate. 
In a spirit similar to Schwatz’s advocation of explicative stipulation, Smith proposes an 
epidemiological account of disease causation which walks the fine line between practi-
cal applicability and theoretical considerations of causal complexity and attempts to com-
promise between patient-centered and population-centered concepts of disease. Smith 
claims that the epidemiological account is the most basic framework consistent with our 
strongly held intuitions about the causal classification of disease, yet it avoids the difficul-
ties encountered by its competitors. 
A further question about genetic and other diseases is “why do they persist?” If evolu-
tion favors those who resist disease, one might expect subsequent populations to be less 
and less susceptible to disease. However, there is no evidence that this has happened or 
is happening. In “Why Disease Persists: An Evolutionary Nosology,” Robert Perlman ex-
plains why. Natural selection is not the only process that changes gene frequencies in 
populations; mutation and other processes may introduce or increase the frequency of ge-
netic diseases. Interactions between genes complicate the relationship between genotype 
and phenotype, and may result in the preservation of genetic diseases. 
Variations in environmental resources and random developmental events further 
complicate the genotype–phenotype relationship and may also lead to disease. Natural 
selection increases fitness, but the declining force of natural selection with age is only one 
indication that fitness is not equivalent to the absence of disease. Natural selection acts 
on genes, cells, and groups, as well as on organisms; the outcome of evolution reflects se-
lection at different levels of biological organization. Finally, the human environment is 
continually changing, largely because of the evolution of our parasites and because of 
changes in cultural beliefs and practices; genetic evolution is comparatively slow and lags 
behind environmental change. An evolutionary study of disease complements the tradi-
tional medical approach and enhances our understanding of the persistence of disease. 
Regardless of which approach to defining diseases one takes, there will still be fur-
ther tough questions about specific cases—arguments over whether some purported dis-
ease really is a disease or whether it is properly understood. The papers by Horowitz and 
McKitrick raise such issues about mental illness. 
Horwitz in previous work had used a hybrid notion of disease as a harmful dysfunc-
tion to argue that much of what we call mental illness—e.g. much in DSM IV—are not 
diseases but problems in living. In “Creating Mental Illness in Nondisordered Commu-
nities,” Horwitz looks at assessments of the prevalence of mental illness. Studies claim 
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to show that one in four Americans will have a major depressive episode in their life-
time and one of eight, social anxiety disorder. Yet the latter was described as “rare” 
in DSM III in 1980. These estimates of prevalence are done by strictly adhered to sur-
vey questions analyzed by computer. The surveys are unable to screen out cases where 
symptoms result not from underlying disease but from transient social stresses—de-
pression due to the loss of a loved one gets categorized with depressive episodes of bi-
polar disorder; understandable nervousness for someone who rarely speaks in public 
gets categorized with someone who can never be around more than a couple people. 
There are vested interests—the NIMH and patient advocacy groups—who benefit if the 
estimates of mental illness are high and thus the survey process continues. In this sense 
mental illness is “socially constructed,” for the labeling process is indeed a sociological 
one. Horwitz holds that this is compatible with taking some mental illness to be fully 
objective diseases. 
In “Gender Identity Disorder,” McKitrick examines a condition labeled a mental ill-
ness according to DSM IV. GID is generally thought to occur when a patient has a gen-
der identity that is atypical for his or her biological sex. Gender identity is thus not de-
termined by biological sex. Nor is it, McKitrick argues, determined by psychological 
properties—being effeminate does not mean a man is woman in a man’s body. Thus GID 
assumes there is an essence of gender identity that is independent of biological, psycho-
logical, and social characteristics. McKitrick takes this presupposition to be quite implau-
sible, for if two individuals are identical biologically, psychologically, and socially, then 
they ought to have the same gender (gender should supervene on these traits). The so-
lution to the problem is to see that gender identity has no essence. Gender concepts are 
cluster concepts that cannot be defined in terms of necessary and sufficient conditions. 
This does not mean that gender identity is a mere fiction. People do identify with dif-
ferent genders. Yet gender identity is a cluster concept that varies according to differ-
ing gender norms, not an essence. McKitrick concludes that the DSM IV definition really 
makes GID a matter of nonconformity to gender roles, something it denies. Recognizing 
that GID is a social conflict, not a disorder, calls for greater tolerance of social differences, 
not for treatment of an illness. 
The remaining essays are concerned with the nature and role of evidence in biomedi-
cal science. There is now an exhaustive body of work in the philosophy of science show-
ing that the relations between evidence, theory, explanation, and the social processes of 
science are varied and complex. These essays certainly second that opinion for the case of 
biomedical science. 
In “Clinical Trials as Nomological Machines,” Bluhm raises interesting questions 
about the gold standard for evidence in contemporary medicine, namely, the random-
ized clinical trial. Every drug approved by the US FDA must show efficacy in two Phase 
III clinical trials where the treatment is compared to outcomes in a control group that 
gets either a placebo or sometimes a competing treatment. Bluhm’s main question con-
cerns what success in these trials tells us about what should be done in clinical practice. 
Bluhm’s conclusion: they tell us much less than is commonly claimed. 
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Her argument relies on two concepts from the philosophy of science. The first is the 
idea of nomonological machine. Cartwright argues that experiments in the natural sci-
ences are about realizing a set of specific causal processes that are shielded from outside 
influences. Only in such cases, according to Cartwright, are we to expect science to find 
laws in the sense of universal regularities. Outside of the experimental setup we only 
have knowledge about capacities, not regularities. Clinical trials, Bluhm argues, are at-
tempts to establish nomonological machines—to provide a situation where interfering 
factors are sufficiently controlled that we can have reliable knowledge that the treatment 
caused the observed differences in outcomes. 
The problem for the clinician is trying to tell what the experimental outcome tells us 
about how the treatment will work for the individual patient. There is a widespread ten-
dency to think a successful RCT shows the real effect of the drug. However, it in fact only 
tells us about the drug’s capacity—what it can potentially do—in situations outside the ex-
perimental set up and it does not give us very much information about that capacity. Cli-
nicians thus must “reverse engineer” the experiment. “Reverse engineering” is Dennett 
description of how evolutionary biologists must go about trying to identify function in 
biological organization—by asking how the observed outcome might have been put to-
gether. For clinicians to apply RCT results to their own patients, they need to know all the 
decisions that went into designing the clinical trial in order to make a reasonable judg-
ment about whether the results are relevant to their patient. Published results, however, 
seldom provide the needed information. 
In “The Social Epistemology of NIH Consensus Conferences,” Miriam Solomon also 
applies ideas from recent philosophy of science to a fundamental epistemic practice in 
medicine. The practice is the NIH Consensus Conference. These are designed to influ-
ence the behavior of physicians by bringing together unbiased experts to reach objec-
tive recommendations based on what the evidence shows in a particular area of medicine 
where there currently is controversy and a gap between theory and practice. The ideas 
employed from recent philosophy of science concern the many different ways that bias 
can surface in science as revealed by many historical and case studies. Like Bluhm, Sol-
omon reaches the conclusion that a gold standard in medicine—this time, the Consensus 
Conference—is not nearly as effective as advertised. 
There are two fundamental questions about consensus conferences: do they produce 
objective decisions on controversial treatment decisions and do they change the medical 
practice of physicians on the ground? Solomon argues that they fail in the first goal for 
several reasons. Consensus conferences are preceded by government conducted meta-
analysis of relevant studies and these results are announced before hand. Thus in prac-
tice consensus is often reached before the conference, not by the conference itself. More-
over, there is good evidence that disciplinary biases—biases that everybody in a given 
area share—are not weeded out. For example, a recent conference on dental treatments 
reached entirely different conclusions than the proceeding meta-analysis, but gave no 
explanation why; the most likely explanation is that the meta-analysis failed to show 
that standard dental practices are effective, threatening the interests of dentistry. Fi-
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nally, obvious checks on the reliability of consensus conferences have not been done—
no one has checked to see how frequently their recommendations hold up to further 
scrutiny. 
Solomon concludes that consensus conferences primarily serve a rhetorical function—
persuading physicians who are unlikely to be persuaded by meta-analyses. Solomon pro-
vides a variety of evidence showing that they are not very effective in achieving this goal 
as well and that when they do so, it is by changing reimbursement schemes rather than 
providing a seemingly objective analysis of the evidence. 
Moira Howes in “Maternal Agency and the Immunological Paradox of Pregnancy” 
continues the theme of applying philosophical scrutiny to biomedical evidence. Her tar-
get, however, is not a generalized form of evidence as in Solomon and Bluhm. Rather, she 
focuses on accounts of the immune system in fertility and pregnancy. This has clear prac-
tical import, for immune explanations and treatments are gaining in popularity but have 
undetermined efficacy. 
Howes challenges two assumptions in explanations of the immune system’s role in 
fertility: the ontological assumption that mother and fetus are separate entities and the de-
scription of their relation primarily in terms of conflict. Science studies has shown again 
and again that many assumptions go into the interpretation and explanation of data, as-
sumptions that are sometimes underdetermined by the evidence and that reflect social 
values of scientists. Howes argues for a similar conclusion regarding the standard picture 
of maternal–fetal relations. That picture originated in large in Medawar’s “immunologi-
cal paradox of pregnancy.” The paradox arises because according to Medawar the fetus is 
the immune equivalent of an organ transplant—it is a foreign body. Thus there must be in 
pregnancy various mechanisms to ward off an immune attack on the fetus; herein lies the 
relevance of the immune system to infertility. Other widespread analogies for pregnancy 
are the invasion of cancer cells or of a parasite. 
This picture, Howes argues, is permeated with metaphors that reflect larger social 
values. There is much biological reason to think that the mother and fetus are not two 
separate entities in the way that a host and a parasite are. For example, they exchange 
cells that remain in each other for life. Pregnancy is not a disorder in the way the 
cancer analogy implies nor is the female body merely passive in the process of preg-
nancy as the invasion metaphor suggests. The parasite metaphor ignores the genetic 
ties between mother and fetus and the strong evolutionary reasons to think the moth-
er’s body has a strong interest in protecting the fetus. Dropping the metaphors of for-
eign body, parasite, and invasive disease might help reproductive immunology to de-
velop explanations that are truer to the real biological complexity of pregnancy and 
infertility. 
The last two papers by Kaplan and Gifford are the only two in the volume directly 
concerned with policy and ethical questions. Yet in both cases it is the kind of complex-
ities in biomedical evidence discussed by the other authors that drives the normative 
questions. Kaplan evaluates public health approaches to violence, Gifford, the ethical le-
gitimacy of clinical trials. 
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Violent crime is a serious social problem internationally. In all cases a large propor-
tion of the crimes are committed by a few young males. This fact has led many to sug-
gest that there is a biological explanation for crime and that identifying that biological ba-
sis would provide useful information about how and when to intervene to reduce crime. 
In “Violence and Public Health” Kaplan rejects this conclusion. While he doubts that we 
currently have any very well confirmed understanding of the biology of crime, the main 
thrust of his argument is that even if we did, it would not provide useful information for 
preventing crime. Kaplan identifies two broad biological approaches to violent crime. One 
seeks to find biochemical differences between those who do and do not commit crimes or, 
in a more complex mode, biochemical differences interacting with social differences. De-
ficiencies in MAOA (monoamine oxidase A) in combination with abusive family envi-
ronments is one such explanation that has gotten serious attention. The second approach 
uses evolutionary psychology to treat crime as an adaptive response that is triggered in 
response to environments with low life spans and low levels of social advancement. 
While these explanations are intellectually interesting and might some day be well 
confirmed, Kaplan argues that they are not relevant for what we should do about crime. 
At present we have no biochemical correlate that predicts crime and no way to alter 
MAOA levels even if they were well correlated with criminal behavior. We also have only 
speculative reasons to think crime results from a genetically based strategy that maxi-
mizes reproductive fitness. But we do know that various social interventions can be effec-
tive, that the environments they target would be key explanatory variables in any biolog-
ically based account, and that the results they produce are generally good things for other 
reasons as well. Given this, focusing primarily on the biological basis of crime is an irrele-
vant and potential damaging distraction. Thus Kaplan illustrates well a theme mentioned 
earlier, namely, the complex interplay between value issues and evidence in biomedical 
science. 
Finally, in “Taking Equipoise Seriously” Gifford is concerned about the interplay be-
tween different degrees of evidence and the ethics of conducting clinical trials. The basic 
problem is this: the treating physician has an obligation to provide the patient with the 
best possible care. However, in clinical trials there may be some evidence that one treat-
ment is better than another long before the trial is finished. So how can a physician ethi-
cally enroll a patient to be randomly assigned to either treatment or control if there is evi-
dence that one arm is better? A standard and widely invoked solution Freedman’s (1987) 
notion of “clinical equipoise.” So long as the community of practitioners has not reached 
consensus on which treatment is best, enrolling patients in a trial is justifiable because it is 
not known which treatment is favored. 
Most of Gifford’s chapter consists in showing that this widely accepted answer is in-
herently ambiguous and that as a result the appearance of a solution to the ethical di-
lemma is misleading. Gifford identifies three different sets of variables that have to be 
specified to make Friedman’s claim unambiguous: (1) community can either be taken in 
the narrow sense of experts or in the broad sense of physicians at large, (2) consensus can 
be given either a strict definition as unanimous agreement or a weaker definition as pre-
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ponderance, and (3) community opinion might be on the decision whether the treatment 
should be approved for general use vs. the question of whether I would want to use it 
given what is known now. The latter distinction is motivated by the thought that we have 
higher standards of evidence for what will be generally used by the public than we do for 
decisions only affecting a single individual, echoing the role of consensus conferences dis-
cussed by Solomon. 
With these distinctions in hand, Gifford argues that Friedman’s equipoise solution is 
not supportable. One rationale given for that proposal is that individual physicians ought 
to take into consideration the views of the community, for that is evidence in itself. How-
ever, that justification supports using the preponderance of opinion reading of consensus. 
But if equipoise is disturbed as soon as there is a preponderance of community opinion, 
that can happen early in a clinical trial as the result comes in. So standard practice is still 
not justified. Moreover, even when there is community consensus in either sense about 
what to give an individual, there need not be consensus about whether the treatment in 
question should be publicly available. Yet it is the latter question clinical trials are trying 
to answer. Gifford concludes that there is no easy solution and that we need an explicit 
discussion of how to trade off various values in conducting clinical trials. 
We end by noting one last common element to most of the essays, one visible in Gif-
ford’s conclusion. While various arguments and theses are found implausible by the au-
thors, most do not claim to have the final word on how the various problems discussed 
should be decided. Simplistic solutions can be rejected, but more careful discussion and 
investigation is called for to handle the problems raised. That is a strong indication that 
biomedical science is a fertile ground for ongoing work in applied epistemology and 
metaphysics. 
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